Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Nanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
NantOmics provides molecular testing for cancer, using an integrated panomic approach that combines DNA sequencing, RNA sequencing, and quantitative proteomics to profile a patient's tumor. Its analytical platform delivers molecular diagnostics and decision support to match cancer patients and their providers with targeted treatment options.
0 investors
Nascent Biotech develops proprietary human monoclonal antibodies and immunotherapy for cancer treatment, with a lead therapeutic asset (Pritumumab) validated in brain cancer patients. The company is pursuing novel targets with a broad pipeline of therapies and diagnostics, supported by platform drug delivery technology.
0 investors
0 investors
0 investors
0 investors
Natsar Pharmaceuticals is an applied research and drug development company developing RK-33, a first-in-class small molecule inhibitor of the DDX3 RNA helicase for treating cancers such as lung, breast, prostate, sarcoma, and pancreatic tumors, as well as viral infections including SARS-CoV-2 and HIV. The company is preparing to file an IND and move RK-33 into Phase 1 clinical trials.
0 investors
0 investors
Navega Therapeutics develops gene therapies using zinc-finger and CRISPR-based epigenome regulation to control gene expression. The company works in the biotech and gene therapy space.
0 investors
Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers. The company's flagship NavDx test uses proprietary technology to detect tumor tissue-modified viral HPV DNA in blood plasma, offering high sensitivity and specificity for cancer surveillance.
0 investors
Navrogen is a biopharmaceutical company developing therapeutic agents that counter tumor-produced Humoral Immuno-Oncology (HIO) factors linked to suppressed humoral immunity and poor response to immune-mediated anti-cancer therapies. It uses proprietary screening, antibody engineering technologies, and diagnostic assays to identify patients whose tumors produce HIO factors, targeting cancer and immune-related disorders.
0 investors
0 investors
0 investors
0 investors
0 investors